3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 24 0 0 0 0 0 0 0999 V2000
4.3026 -0.3183 -0.8101 O 0 0 0 0 0 0 0 0 0 0 0 0
-2.0854 -2.5871 -0.2566 O 0 5 0 0 0 0 0 0 0 0 0 0
-0.0568 -2.2526 0.5127 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.3970 0.5087 0.2861 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.1378 1.6691 -0.4247 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1536 -1.7986 0.0752 N 0 3 0 0 0 0 0 0 0 0 0 0
0.9364 0.2311 0.8065 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0004 0.0696 -0.2785 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9121 1.7441 0.0444 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3368 -0.4166 -0.0427 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4003 -0.1603 0.2773 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4088 0.3248 -0.4809 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1515 2.9861 0.2914 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9108 -0.5883 1.5267 H 0 0 0 0 0 0 0 0 0 0 0 0
1.2126 1.0925 1.4281 H 0 0 0 0 0 0 0 0 0 0 0 0
2.0162 0.9531 -0.9295 H 0 0 0 0 0 0 0 0 0 0 0 0
1.7387 -0.7627 -0.9440 H 0 0 0 0 0 0 0 0 0 0 0 0
3.4308 -1.0661 0.8909 H 0 0 0 0 0 0 0 0 0 0 0 0
3.7248 0.6930 0.8809 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.3644 -0.0346 -0.8361 H 0 0 0 0 0 0 0 0 0 0 0 0
0.8054 2.9836 -0.2385 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.7188 3.8539 -0.0610 H 0 0 0 0 0 0 0 0 0 0 0 0
0.0336 3.1267 1.3608 H 0 0 0 0 0 0 0 0 0 0 0 0
5.1853 -0.4633 -0.4288 H 0 0 0 0 0 0 0 0 0 0 0 0
1 11 1 0 0 0 0
1 24 1 0 0 0 0
2 6 1 0 0 0 0
3 6 2 0 0 0 0
4 7 1 0 0 0 0
4 9 1 0 0 0 0
4 10 1 0 0 0 0
5 9 2 0 0 0 0
5 12 1 0 0 0 0
6 10 1 0 0 0 0
7 8 1 0 0 0 0
7 14 1 0 0 0 0
7 15 1 0 0 0 0
8 11 1 0 0 0 0
8 16 1 0 0 0 0
8 17 1 0 0 0 0
9 13 1 0 0 0 0
10 12 2 0 0 0 0
11 18 1 0 0 0 0
11 19 1 0 0 0 0
12 20 1 0 0 0 0
13 21 1 0 0 0 0
13 22 1 0 0 0 0
13 23 1 0 0 0 0
M CHG 2 2 -1 6 1
4. 国际命名与标识
4.1 IUPAC Name
3-(2-methyl-5-nitroimidazol-1-yl)propan-1-ol
4.2 InChl
InChI=1S/C7H11N3O3/c1-6-8-5-7(10(12)13)9(6)3-2-4-11/h5,11H,2-4H2,1H3
4.3 InChlKey
DUOHVNSMLSPTMI-UHFFFAOYSA-N
4.4 Canonical SMILES
CC1=NC=C(N1CCCO)[N+](=O)[O-]
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病